Skip to main content
. 2024 Sep 25;386:e079921. doi: 10.1136/bmj-2024-079921

Table 2.

Parameter estimates calculated with the mixed effect model for the primary outcome of the patient health questionnaire anxiety and depression scale

Analysis type No. of people in control group Control group, mean (SD) No. of people in intervention group Intervention group, mean (SD) Minimally adjusted mixed model analysis (95% CI)* P value Effect size (minimally adjusted mixed model) (95% CI) Adjusted mixed model analysis (95% CI)† P value Effect size (adjusted mixed model) (95% CI)
Baseline (six months) 189 26 (7.5) 187 27 (7.8)
Intention to treat 189 19 (9.8) 187 17 (10) −2.43 (−4.48 to −0.38) 0.02 0.21 (0.03 to 0.39) −2.26 (−4.28 to −0.23) 0.03 0.21 (0.02 to 0.39)
Intention to treat, complete case 112 18 (9.5) 125 17 (10) −1.37 (−3.60 to 0.92) 0.23 0.08 (−0.05 to 0.21) −1.45 (−3.62 to 0.79) 0.20 0.09 (−0.05 to 0.22)
Per protocol 85 17 (9.4) 97 17 (11) −1.63 (−4.27 to 1.06) 0.23 0.09 (−0.06 to 0.24) −2.00 (−4.54 to 0.56) 0.13 0.12 (−0.03 to 0.27)
As treated 93 17 (9.1) 144 18 (11) −0.98 (−3.28 to 1.37) 0.41 0.05 (−0.08 to 0.18) −1.25 (−3.50 to 1.05) 0.29 0.07 (−0.06 to 0.20)
Sensitivity dataset 124 18 (9.2) 78 17 (10) −1.82 (−4.29 to 0.70) 0.15 0.10 (−0.04 to 0.24) −2.03 (−4.45 to 0.42) 0.11 0.12 (−0.02 to 0.26)

Effect size measured with Cohen’s d.

CI=confidence interval.

*

Intervention v control condition; mixed effect linear regression model minimally adjusted for the respective baseline score and centre.

Intervention v control condition; mixed effect linear regression models adjusted for the respective baseline score, age, gender, history of depression or anxiety, SF-12 Physical Component Score, chronic medical disease, and no. of days between baseline assessment and randomisation.